Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From medac GmbH
India’s COVID-19 immunization focus has shifted to children as over 88% adults are fully vaccinated. However, Scrip’s examination of weekly data reveals the number of doses given to children are also dropping sharply off peaks. Meanwhile, Biological E is winning over others like Novavax in this segment while Zydus Lifesciences is yet to score
Deals show large investors’ appetite for early-stage biotech, but can VC and PE rub along?
Biosimilar licensing agreement also includes option on Yervoy-based product. Oxford BioTherapeutics, ImmunoGen pair their technologies for development of novel cancer ADCs.
National Resilience, Parker Institute team to incubate cancer startups. Metropolitan AntiViral Drug Accelerator will focus on eight molecular features of SARS-CoV-2 to create novel oral antivirals.
- In Vitro Diagnostics
- Medical Devices
- Drug Delivery
- Generic Drugs
- Other Names / Subsidiaries
- medac Gesellschaft für klinische Spezialpräparate mbH
- medac GmbH Sp. z o.o.